Souhaitez-vous accéder aux communiqués récents ?

New investors include ArrowMark, LifeSci Venture Partners, and strategic partner, DexcomRTW made an additional Series B investmentStrategic partner, Zealand Pharma completed $5 million Series B...

Antibiotic Resistance Market (By Disease - cUTI, cIAI, BSI, CDI, ABSSSI, HABP/VABP, CABP; By Pathogen - Acinetobacter Baumannii, Pseudomonas Aeruginosa, Staphylococcus Aureus, E. coli/K. Pneumoniae,...

DELANO, Minn. and FORT WAYNE, Ind., Jan. 08, 2019 (GLOBE NEWSWIRE) -- Trelleborg, a world leader in engineered polymer solutions has, through its business area Trelleborg Sealing Solutions, fully...

NEW YORK, Jan. 08, 2019 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you...

WALTHAM, Mass., Jan. 08, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced that it has been named a CES® 2019 Innovation Awards Honoree for Quell® 2.0 Wearable Pain Relief...

- Closes transaction to complete 51% acquisition of Olaregen Therapeutix - Plans Commercial Launch of FDA-cleared Excellagen® MIRAMAR, Fla., Jan. 08, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE --...

LOS ANGELES, Jan. 08, 2019 (GLOBE NEWSWIRE) -- The global sterility indicators market is anticipated to reach USD 1.24 billion by 2025 in terms of revenue. It is expected to grow at a CAGR of 10.8%...

NEW YORK and CLEVELAND, Jan. 08, 2019 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene...

LOS ANGELES, Jan. 08, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Alkermes plc (“Alkermes” or...

DENVER, CO, Jan. 08, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Phoenix Life Sciences International Limited (OTC: PLSI) (“Phoenix Life”, or the “Company”), an international adaptive healthcare...

NEWTON, Mass., Jan. 08, 2019 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company, today announced that it has submitted a Marketing Authorization...

Washington, D.C., Jan. 08, 2019 (GLOBE NEWSWIRE) -- While consumers cite broad aspects like taste, price and familiarity as the top reasons to purchase certain foods, they also crave a deeper...

NEW YORK, Jan. 08, 2019 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed Alkermes plc, Inc....

Dublin, Jan. 08, 2019 (GLOBE NEWSWIRE) -- The "Investigation Report on China's Loratadine Market, 2018-2022" report has been added to ResearchAndMarkets.com's offering. The...

FREMONT, Calif., Jan. 08, 2019 (GLOBE NEWSWIRE) -- Cytek Biosciences Inc., a leading provider of flow cytometry instrumentation, today announced that its Aurora and Northern Lights series of flow...

Alexandria, VA, Jan. 08, 2019 (GLOBE NEWSWIRE) -- Alexandria, VA – More than 7 in 10 Americans (72 percent) say bottled water (still and/or sparkling) is among their most preferred non-alcoholic...

MINNEAPOLIS, Jan. 08, 2019 (GLOBE NEWSWIRE) -- Relievant Medsystems, a privately-held medical device company developing minimally-invasive solutions for chronic low back pain (CLBP), today announced...

PALO ALTO, Calif., Jan. 08, 2019 (GLOBE NEWSWIRE) -- Cognoa, a digital behavioral health company, announced today that Cambia Health Solutions, Inc. (Cambia) is incorporating Cognoa’s evidence-based...

NEW YORK, Jan. 08, 2019 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (“AXIM® Biotech” or “AXIM”) (OTCQB: AXIM), a world leader in cannabinoid research and development, today announced the...

BOSTON, Jan. 08, 2019 (GLOBE NEWSWIRE) -- Recent launches of new active substances (NAS) and a strong R&D pipeline indicate that recent global drug development not only has been robust, but also...

MCLA-145 ist ein menschlicher bispezifischer Antikörper in voller Länge, der an PD-L1 und CD137 bindet UTRECHT (Niederlande, Jan. 08, 2019 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS), ein...

Le MCLA-145 est un anticorps bispécifique humain complet se liant au PD-L1 et au CD137 UTRECHT, Pays-Bas, 08 janv. 2019 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq : MRUS), entreprise d'immuno-oncologie...

CEO Explains How 2019 is the Breakout Year MIAMI, FL, Jan. 08, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Novus Acquisition and Development, Corp. (OTC Markets: NDEV), through its wholly owned...

Aligned with FDA on Phase 3 Registration-Enabling Trial for Galinpepimut-S (GPS) in Acute Myeloid Leukemia; Trial Expected to Start in Q2 2019 Enrollment of Phase 1/2 Basket Trial of GPS plus...

VALLEY COTTAGE, N.Y. , Jan. 08, 2019 (GLOBE NEWSWIRE) -- Future Market Insights provides key insights on the global microcrystalline cellulose market in its latest report titled “Microcrystalline...

Newark, NJ, Jan. 08, 2019 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc., a leader in the growing field of cancer metabolism-based therapeutics, today announced the initiation of patient...

CARLSBAD, Calif., Jan. 08, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today provided...

BEVERLY, Mass., Jan. 08, 2019 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage pharmaceutical company, is pleased to inform shareholders of recent...

SCOTTSDALE, Ariz., Jan. 08, 2019 (GLOBE NEWSWIRE) -- The Alkaline Water Company Inc. (NASDAQ and TSXV: WTER), a leading producer of premium bottled alkaline drinking water sold under the brand name...

NEW YORK, Jan. 08, 2019 (GLOBE NEWSWIRE) -- Brooklyn Minds, a concierge mental health facility providing comprehensive and highly collaborative child, adolescent and adult mental health services,...

BASKING RIDGE, N.J., Jan. 08, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced two clinical studies focused on expanding...

Peabody, MA, Jan. 08, 2019 (GLOBE NEWSWIRE) -- TÜV SÜD America Inc., a premium quality, safety, and sustainability solutions provider that specializes in testing, inspection, auditing,...

Singapore, Jan. 08, 2019 (GLOBE NEWSWIRE) -- Singapore, 8 January 2019 – AWAK Technologies (AWAK), a pioneering medical technology company focused on dialysis using regeneration technology for...

VANCOUVER, Washington, Jan. 08, 2019 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), a biotechnology company developing a novel humanized CCR5 monoclonal antibody for multiple therapeutic...

Leverkusen, Germany, Jan. 08, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today announced that...

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Press ReleaseNicox Reaches 50%...

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Communiqué de presseNicox atteint...

Crizanlizumab is a monthly infusion under development to prevent pain crises (also called vaso-occlusive crises, or VOCs) in patients with sickle cell disease Sickle cell VOCs, which are...

NEW YORK, Jan. 07, 2019 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies....

NEW YORK and MELBOURNE, Australia, Jan. 07, 2019 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB; Nasdaq:MESO), world leader in the development and commercialization of cellular medicines, today...

NEW YORK, Jan. 07, 2019 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous...

LA JOLLA, Calif., Jan. 07, 2019 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock...

reSET-O(TM)* is the first US FDA-cleared prescription digital therapeutic for patients with Opioid Use Disorder Cleared by the FDA in December, reSET-O is available immediately As part of a...

NEW YORK, Jan. 07, 2019 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP announces that a federal securities class action lawsuit has been filed in the United States District for...

BOSTON, Jan. 07, 2019 (GLOBE NEWSWIRE) -- Ziopharm Oncology, Inc. (Nasdaq:ZIOP) today posted and released the following letter: Dear Fellow Stockholders, With the 37th Annual J.P. Morgan...

Announces closing of 51% acquisition of regenerative medicine company Regentys™Regentys Extracellular Matrix Hydrogel for the Treatment of Ulcerative Colitis and Other Inflammatory Bowel Diseases ...

La collaboration comporte dans un premier temps neuf nouveaux essais cliniques de phase I/II avec NBTXR3, premier produit d’une nouvelle classe de Nanobiotix, dans six types de cancer différents -...

Collaboration will initially support nine new phase I/II clinical trials with Nanobiotix’s first-in-class agent NBTXR3 for use in treating six cancer types - head and neck, pancreatic, thoracic, lung,...

NEW YORK, Jan. 07, 2019 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Immunomedics, Inc....

TORONTO and LOS ANGELES, Jan. 07, 2019 (GLOBE NEWSWIRE) -- eSight, creators of the world's most advanced sight-enhancing glasses for the visually impaired, is proud to announce the single largest...